Abstract
<h3>Objective:</h3> N/A <h3>Background:</h3> Early-onset Alzheimer’s Disease (EOAD) affects patients younger than age 65 and may present with non-amnestic features. Black patients are half as likely to be diagnosed despite twice as many risk factors. Ethnic disparities in EOAD have not been fully characterized. <h3>Design/Methods:</h3> We retrospectively identified EOAD patients February 2017–February 2022 and collected data on ethnicity, level of education, Montreal Cognitive Assessment (MoCA) scores and clinical presentation. <h3>Results:</h3> Of 88 total patients, 60 (68.8%) identified as Caucasian/White and 28 (31.8%) identified as African American/Black. Age at diagnosis (years) was (57.3 ± 5.24) in Black patients compared to (55.9 ± 5.69) in White patients. Time to diagnosis (years) was on average longer in Black patients (5 ± 9.21) compared with White patients (3.5 ± 6.44) and Black patients were on average more advanced (total MOCA scores) at presentation (12.17 ± 6.91) compared with White patients (15.15 ± 5.92) despite similar education level (in years) among Black patients (14.71 ± 2.30) and White patients (15.21±3.00). An amnestic profile was more common in Black patients (19 or 67.9%) than non-amnestic presentations (9 or 32.1%), although 2 patients (7.14%) presented with visual symptoms suggestive of posterior cortical atrophy (PCA), 5 (17.9%) patients had prominent language symptoms suggestive of logopenic primary progress aphasia (l-PPA) and 1 (3.6%) patient had an executive presentation, suggestive of frontal variant of AD (fAD). Comparatively, non-amnestic presentations were more commonly diagnosed in White patients, with 11 (18.3%) PCA diagnoses, 10 (16.7%) patients with fAD and 8 (13.3%) patients with l-PPA. <h3>Conclusions:</h3> In our cohort, Black patients with EOAD are on average older, more advanced and experience longer delays in diagnosis than their White counterparts. Non-amnestic presentations are more common in White patients. Further work is needed to further characterize the barriers to diagnosis accessibility of care for Black patients with EOAD. <b>Disclosure:</b> Ms. Yang has nothing to disclose. Dr. Yoon has nothing to disclose. Ms. Covaciu has nothing to disclose. The institution of Dr. Seibert has received research support from Retirement Research Foundation. The institution of Dr. Seibert has received research support from Center for Healthcare Delivery Science and Innovation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.